Pedro Eerdmans

3.8k total citations · 1 hit paper
17 papers, 1.4k citations indexed

About

Pedro Eerdmans is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Pedro Eerdmans has authored 17 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 8 papers in Cardiology and Cardiovascular Medicine and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Pedro Eerdmans's work include Coronary Interventions and Diagnostics (8 papers), Nitric Oxide and Endothelin Effects (4 papers) and Cardiac Valve Diseases and Treatments (4 papers). Pedro Eerdmans is often cited by papers focused on Coronary Interventions and Diagnostics (8 papers), Nitric Oxide and Endothelin Effects (4 papers) and Cardiac Valve Diseases and Treatments (4 papers). Pedro Eerdmans collaborates with scholars based in Netherlands, Switzerland and United Kingdom. Pedro Eerdmans's co-authors include E.H.J. Weil, R.A. Janknegt, Stephan Windecker, Carlo Di Mario, Peter Jüni, Robert‐Jan van Geuns, Marie‐Claude Morice, Roberto Corti, Franz R. Eberli and Paweł Buszman and has published in prestigious journals such as The Lancet, European Heart Journal and British Journal of Pharmacology.

In The Last Decade

Pedro Eerdmans

17 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial

2008 453 citations Stephan Windecker, Patrick W. Serruys et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pedro Eerdmans Netherlands	12	1.1k	715	382	358	352	17	1.4k
Rafael Payá Spain	15	358 0.3×	589 0.8×	91 0.2×	92 0.3×	28 0.1×	46	1.1k
David Shemesh Israel	17	434 0.4×	75 0.1×	534 1.4×	17 0.0×	54 0.2×	48	845
C.G. Stief Germany	10	206 0.2×	47 0.1×	39 0.1×	139 0.4×	76 0.2×	31	464
Saranatra Waikakul Thailand	17	689 0.7×	21 0.0×	162 0.4×	26 0.1×	193 0.5×	62	1.0k
Nobushige Tamura Japan	15	374 0.4×	289 0.4×	265 0.7×	34 0.1×	11 0.0×	48	659
Hamza Alizai United States	22	870 0.8×	66 0.1×	73 0.2×	17 0.0×	891 2.5×	42	1.6k
Ueli Studler Switzerland	16	374 0.4×	48 0.1×	129 0.3×	11 0.0×	148 0.4×	32	756
Yong In South Korea	28	2.0k 1.9×	41 0.1×	37 0.1×	76 0.2×	486 1.4×	140	2.4k
Vasileios Kontogeorgakos Greece	21	726 0.7×	96 0.1×	224 0.6×	6 0.0×	160 0.5×	94	1.1k
Jeffrey L. Kaufman United States	21	748 0.7×	205 0.3×	587 1.5×	30 0.1×	9 0.0×	59	1.3k

Countries citing papers authored by Pedro Eerdmans

Since Specialization

Citations

This map shows the geographic impact of Pedro Eerdmans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro Eerdmans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro Eerdmans more than expected).

Fields of papers citing papers by Pedro Eerdmans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pedro Eerdmans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro Eerdmans. The network helps show where Pedro Eerdmans may publish in the future.

Co-authorship network of co-authors of Pedro Eerdmans

This figure shows the co-authorship network connecting the top 25 collaborators of Pedro Eerdmans. A scholar is included among the top collaborators of Pedro Eerdmans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pedro Eerdmans. Pedro Eerdmans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

1.

Lipiecki, Janusz, Philippe Brunel, Marie‐Claude Morice, et al.. (2018). Biolimus A9 polymer-free coated stents in high bleeding risk patients undergoing complex PCI: evidence from the LEADERS FREE randomised clinical trial. EuroIntervention. 14(4). e418–e425. 19 indexed citations

2.

Ghione, Matteo, Joanna J. Wykrzykowska, Stephan Windecker, et al.. (2016). Five-year outcomes of chronic total occlusion treatment with a biolimus A9-eluting biodegradable polymer stent versus a sirolimus-eluting permanent polymer stent in the LEADERS all-comers trial. Cardiology Journal. 23(6). 626–636. 4 indexed citations

3.

Urban, Philip, Mariano Valdés, Ian Menown, et al.. (2015). Outcomes following implantation of the biolimus A9‐eluting BioMatrix coronary stent: Primary analysis of the e‐BioMatrix registry. Catheterization and Cardiovascular Interventions. 86(7). 1151–1160. 9 indexed citations

4.

Zhang, Yao‐Jun, Javaid Iqbal, Stephan Windecker, et al.. (2014). Biolimus-eluting stent with biodegradable polymer improves clinical outcomes in patients with acute myocardial infarction. Heart. 101(4). 271–278. 12 indexed citations

5.

Stefanini, Giulio, Bindu Kalesan, Patrick W. Serruys, et al.. (2011). Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial. The Lancet. 378(9807). 1940–1948. 245 indexed citations

6.

Garg, Scot, Giovanna Sarno, Ton de Vries, et al.. (2010). The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymer. EuroIntervention. 6(2). 233–239. 39 indexed citations

7.

Barlis, Peter, E. Regar, Patrick W. Serruys, et al.. (2009). An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study. European Heart Journal. 31(2). 165–176. 185 indexed citations

8.

Windecker, Stephan, Patrick W. Serruys, Simon Wandel, et al.. (2008). Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial. The Lancet. 372(9644). 1163–1173. 453 indexed citations breakdown →

9.

Weil, E.H.J., et al.. (2000). Sacral Root Neuromodulation in the Treatment of Refractory Urinary Urge Incontinence: A Prospective Randomized Clinical Trial. European Urology. 37(2). 161–171. 141 indexed citations

10.

Weil, E.H.J., J.L. Ruiz-Cerdá, Pedro Eerdmans, R.A. Janknegt, & Philip E.V.A. van Kerrebroeck. (1998). Clinical results of sacral neuromodulation for chronic voiding dysfunction using unilateral sacral foramen electrodes. World Journal of Urology. 16(5). 313–321. 99 indexed citations

11.

Weil, E.H.J., Pedro Eerdmans, Karl Tamussino, et al.. (1998). Randomized double-blind placebo-controlled multicenter evaluation of efficacy and dose finding of midodrine hydrochloride in women with mild to moderate stress urinary incontinence: a phase II study. International Urogynecology Journal. 9(3). 145–150. 21 indexed citations

12.

Janknegt, R.A., E.H.J. Weil, & Pedro Eerdmans. (1997). Improving neuromodulation technique for refractory voiding dysfunctions: Two-stage implant. Urology. 49(3). 358–362. 151 indexed citations

13.

Eerdmans, Pedro, et al.. (1996). Impaired arterial reactivity following cytomegalovirus infection in the immunosuppressed rat. British Journal of Pharmacology. 119(4). 637–646. 5 indexed citations

14.

Janssen, Ben, Pedro Eerdmans, & Jos F.M. Smits. (1994). Mechanisms of renal vasoconstriction following furosemide in conscious rats. Naunyn-Schmiedeberg s Archives of Pharmacology. 349(5). 528–537. 14 indexed citations

15.

Boonen, Harrie C. M., Mat J.A.P. Daemen, Pedro Eerdmans, et al.. (1993). Mesenteric Small Artery Changes After Vasoconstrictor Infusion in Young Rats. Journal of Cardiovascular Pharmacology. 22(3). 388–395. 28 indexed citations

16.

Eerdmans, Pedro, H.A.J. Struyker Boudier, & Jo G. R. De Mey. (1991). Contractile reactivity of isolated resistance arteries after 4 weeks of treatment with rilmenidine, clonidine or hydralazine in spontaneously hypertensive rats. Journal of Hypertension. 9. S350–S350. 1 indexed citations

17.

Eerdmans, Pedro, H.A.J. Struyker Boudier, & Jo G. R. De Mey. (1991). Contractile reactivity of isolated resistance arteries after 4 weeks of treatment with rilmenidine, clonidine or hydralazine in spontaneously hypertensive rats. Journal of Hypertension. 9(6). S350–S350. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact